Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929617 · ClinicalTrials.gov registry record · NA
Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 374
- Enrollment target
NCT00929617: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT00929617 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 374 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00929617, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 374 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the effects of one exercise/counseling protocol with usual care on long term exercise adherence and on changes in health related outcomes after breast cancer diagnosis.
Primary Outcome
Physical activity will be measured with accelerometers and self-report questionnaire. Change will be calculated as difference between baseline and 3 endpoints (3, 6 and 12 months).
Interventions
- BEHAVIORAL Experimental 1: exercise with 2 counseling types
- OTHER Usual Care - written materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT00929617 record still lists
NCT00929617 is an interventional study that assigns participants to a tested intervention. The registered 374 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental 1: exercise with 2 counseling types is the first listed.
NCT00929617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00929617 about?
NCT00929617 is a clinical study titled "Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)". The purpose of the study is to compare the effects of one exercise/counseling protocol with usual care on long term exercise adherence and on changes in health related outcomes after breast cancer diagnosis.
What is the current status of trial NCT00929617?
This trial is currently completed. It is a NA study. The enrollment target is 374 participants. The study started on 2009-06. Estimated completion is 2017-03.
What interventions are being tested in trial NCT00929617?
The interventions under investigation include: Experimental 1: exercise with 2 counseling types (BEHAVIORAL), Usual Care - written materials (OTHER).
Who is sponsoring clinical trial NCT00929617?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00929617's enrollment target sits among peer trials
374 280th of 2000 higher than 1,721 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia